Evidence map›Paper›PMID 11105752›Full record

ArticleRNA (New York, N.Y.)2000

Crystal structure of an RNA duplex containing phenyl-ribonucleotides, hydrophobic isosteres of the natural pyrimidines.

G Minasov, J Matulic-Adamic, C J Wilds, P Haeberli, N Usman, L Beigelman, M Egli

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The expanded genetic alphabet.Angewandte Chemie (International ed. in English) · 2015
    Review
  2. Article
  3. Review
  4. The structural basis of myotonic dystrophy from the crystal structure of CUG repeats.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

G MinasovDepartment of Molecular Pharmacology and Biological Chemistry and The Drug Discovery Program, Northwestern University Medical School, Chicago, Illinois 60611, USA.
J Matulic-Adamic
C J Wilds
P Haeberli
N Usman
L Beigelman
M Egli

Funding

STRUCTURE/FUNCTION OF NUCLEIC ACID THERAPEUTICSR01GM055237 · NIGMS · VANDERBILT UNIVERSITY · PI EGLI, MARTIN · 1997 to 2012
$3.3M
NIGMS NIH HHS GM55237
6 · The paper itself

Abstract

Chemically modified nucleotide analogs have gained widespread popularity for probing structure-function relationships. Among the modifications that were incorporated into RNAs for assessing the role of individual functional groups, the phenyl nucleotide has displayed surprising effects both in the contexts of the hammerhead ribozyme and pre-mRNA splicing. To examine the conformational properties of this hydrophobic base analog, we determined the crystal structure of an RNA double helix with incorporated phenyl ribonucleotides at 1.97 A resolution. In the structure, phenyl residues are engaged in self-pairing and their arrangements suggest energetically favorable stacking interactions with 3'-adjacent guanines. The presence of the phenyl rings in the center of the duplex results in only moderate changes of the helical geometry. This finding is in line with those of earlier experiments that showed the phenyl analog to be a remarkably good mimetic of natural base function. Because the stacking interactions displayed by phenyl residues appear to be similar to those for natural bases, reduced conformational restriction due to the lack of hydrogen bonds with phenyl as well as alterations in its solvent structure may be the main causes of the activity changes with phenyl-modified RNAs.

Indexed as

Nucleic Acid ConformationBase SequenceCrystallizationCrystallography, X-RayFourier AnalysisIndicators and ReagentsModels, MolecularMolecular Sequence DataNuclear Magnetic Resonance, BiomolecularOligoribonucleotidesRNARNA, CatalyticRNA, Double-StrandedRNA SplicingIndicators and ReagentsOligoribonucleotidesRNARNA, CatalyticRNA, Double-Stranded

Identifiers

PMID11105752
PMCPMC1370022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.